Short Interest in Crescent Capital BDC, Inc. (NASDAQ:CCAP) Decreases By 12.4%

Crescent Capital BDC, Inc. (NASDAQ:CCAP) was the target of a significant decline in short interest in December. As of December 31st, there was short interest totalling 87,700 shares, a decline of 12.4% from the December 15th total of 100,100 shares. Based on an average daily trading volume, of 105,200 shares, the days-to-cover ratio is currently 0.8 days.

Institutional Investors Weigh In On Crescent Capital BDC

Several large investors have recently bought and sold shares of CCAP. Sun Life Financial Inc. increased its position in Crescent Capital BDC by 20.7% during the third quarter. Sun Life Financial Inc. now owns 2,226,308 shares of the company’s stock valued at $41,187,000 after acquiring an additional 382,542 shares during the last quarter. Kovitz Investment Group Partners LLC bought a new position in Crescent Capital BDC in the third quarter worth approximately $4,878,000. International Assets Investment Management LLC bought a new stake in shares of Crescent Capital BDC during the 3rd quarter valued at $1,899,000. Franklin Resources Inc. increased its stake in shares of Crescent Capital BDC by 35.2% in the 3rd quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after purchasing an additional 66,713 shares in the last quarter. Finally, Millennium Management LLC raised its holdings in Crescent Capital BDC by 31.9% in the 2nd quarter. Millennium Management LLC now owns 268,097 shares of the company’s stock worth $5,035,000 after purchasing an additional 64,902 shares during the period. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Stock Down 0.1 %

NASDAQ:CCAP traded down $0.02 during mid-day trading on Friday, hitting $19.34. 74,403 shares of the company’s stock were exchanged, compared to its average volume of 94,750. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.26 and a quick ratio of 1.26. The company has a market cap of $716.74 million, a PE ratio of 7.58 and a beta of 0.81. The business has a fifty day moving average price of $19.29 and a 200 day moving average price of $18.76. Crescent Capital BDC has a one year low of $15.91 and a one year high of $20.03.

Crescent Capital BDC Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st were issued a $0.42 dividend. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.69%. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 65.88%.

Wall Street Analyst Weigh In

CCAP has been the subject of a number of research analyst reports. Keefe, Bruyette & Woods upped their target price on Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Monday, November 25th. LADENBURG THALM/SH SH assumed coverage on Crescent Capital BDC in a research note on Monday, September 30th. They issued a “buy” rating and a $20.00 target price for the company. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.17.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.